ClinicalTrials.govpublic full text
Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy
duchenne muscular dystrophy, cardiomyopathy, heart failure, nebivolol, beta-blockade treatment, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 967440
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.